Patient Pathfinder: Clinical Trials
Clinical Trials for Myelodysplastic Syndrome
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 166 active Myelodysplastic Syndrome trials
Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
Study Type: Interventional Phase 2
Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
Study Type: Interventional Phase 2
Revlimid in Transfusion Dependent Patients
Study Type: Interventional Phase 2
Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia
Study Type: Interventional Phase 1
US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia
Study Type: Interventional Phase 2
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
Study Type: Observational
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Study Type: Interventional Phase 1
There are 166 active Myelodysplastic Syndrome trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now